Chapter 25: Endocrine Pathology

0:00 / 0:00
Report an issue

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement, not replace, the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

You know, usually when we talk about how the human body works, we tend to think in terms of mechanics.

We picture the heart as a pump, the lungs as bellows, the skeleton as a scaffold.

It's all very structural.

Plumbing and carpentry, basically.

Exactly.

It's plumbing and carpentry.

But today, we are looking at the software.

That is a great way to put it.

We are moving away from the pipes and looking at the code.

We're diving into the chemical signals that actually tell those pumps and scaffolds what to do.

We are cracking open Chapter 25 of the USMLE Step 1 Lecture Notes, Pathology from 2017.

And reading through this chapter on endocrine pathology, I realize that this isn't really a story about diseases in the traditional sense.

It's a story about communication breakdowns.

It is.

The endocrine system is the body's long -distance communication network.

You have these glands, the thyroid in the neck, the adrenals in the abdomen, the pituitary in the brain, sitting in completely different zip codes, but they are constantly talking to each other, and the language they speak is hormones.

And the margin for error here is terrifyingly small.

It's microscopic.

If a gland whispers when it should shout, or shouts when it should be silent, the effects aren't just local, they are systemic.

Systemic.

They change the way you metabolize energy, the way you handle stress, the way your heart beats.

That's our mission for this deep dive.

We aren't just going to memorize a list of tumors.

We are going to trace the signal.

We're going to walk sequentially through this chapter from the neck down to the abdomen and up to the brain, decoding these feedback loops.

We want to see what happens when the volume gets turned up too high, like engraved disease, or when the line gets cut entirely.

And because this is a pathology deep dive, we have to look at the wreckage.

When we discuss these notes, we'll be visualizing the histology.

What these communication failures actually look like under a microscope.

We need to see the tissue.

We need to see the tissue changes that explain the symptoms.

So buckle up.

We are starting with the metabolic throttle of the body, the thyroid gland.

The thyroid is a great place to start because it really illustrates the concept of feedback.

The text jumps right in with a condition that I think many people have heard of, but few understand the mechanics of, the multinodular goiter.

Right.

Now, culturally, we have this image of a goiter as just a massive, disfiguring neck lump.

But the text makes a very specific distinction right out of the gate between toxic and non -toxic.

And this is the first fork in the road for diagnosis.

You have a patient with an enlarged thyroid.

That's the goiter.

But non -toxic simply means the gland is big, but it's not poisoning the patient with excess hormone.

Okay.

Clinically, these patients are euthyroid.

Which is a strange paradox if you start to think about it.

You have a gland that is physically hyperplastic.

It's growing larger.

But functionally, the labs are normal.

Yeah.

The T4, T3, and TSH are all within standard range.

Why does the gland grow if it doesn't plan to work harder?

It's usually trying to compensate.

Think of it like a factory that's struggling to meet a quota.

Maybe there's a slight iodine deficiency or a minor blockage in hormone synthesis.

The gland isn't making enough hormone per cell, so TSH, the manager from the pituitary gland, yells at it to expand.

The cells multiply.

The factory gets bigger just to maintain the same baseline output.

So the enlargement is a sign of struggle, not strength.

Exactly.

And structurally, this leads to the multinodular goiter.

It's not a clean, uniform growth.

You get these uneven, bumpy nodules filled with colloid.

It's a messy architecture.

And looking at the histology description in the notes, it sounds like a battlefield.

It does.

You see nodules of varying sizes.

But because this is a chronic process, you see signs of wear and tear.

The text lists calcification, hemorrhage, cystic degeneration, and fibrosis.

It's a gland that has been stressing its structural integrity for years.

But the text mentions a plot twist here.

It mentions something called Plummer's Syndrome.

This is where the nontoxic situation changes.

Right.

This is where the nontoxic goiter goes rogue.

Goes rogue.

I like that.

Imagine that struggling factory we talked about.

Eventually, one of those new nodules stops listening to the manager.

It mutates.

It becomes autonomous.

It becomes autonomous.

It starts pumping out thyroid hormone regardless of what the body needs.

So it ignores the feedback loop.

Completely.

And that is Plummer's Syndrome, a toxic multinodular goiter.

It usually happens late in the course of the disease.

So you have a patient who has had a lump for years with no issues, and suddenly they develop hyperthyroidism.

And that segues us perfectly into the state of hyperthyroidism itself.

The text calls this the high idle state, which I think is a billion analogy.

It is.

Thyroid hormone basically controls the basal metabolic rate.

It sets the tempo for every cell in the body.

OK.

If you have hyperthyroidism, whether it's from Plummer's Syndrome or Graves' disease,

your idle is set too high.

So the engine is racing even when the car is parked.

Precisely.

And the symptom list flows directly from that concept.

Patients are burning energy so fast they are literally overheating.

That's the heat intolerance and sweating.

They are losing weight despite having a ravenous appetite because the furnace is burning everything they eat.

And the heart.

What's happening to the heart?

The heart is racing, tachycaria, palpitations.

The gut is moving too fast, so you get diarrhea.

It's a state of sympathetic overdrive.

Now, the notes list a stare as a symptom.

And I want to be careful here because we often conflate staring with the bulging eyes of Graves' disease.

But the text treats them as distinct concepts.

That is a crucial distinction and a classic trap for students.

The stare, where the eyelids retract and you see the white of the sclera above the iris, that can happen in any type of hyperthyroidism.

OK, so what's the mechanism there?

How does that work?

It's purely sympathetic tone.

The high thyroid hormone makes the muscle that lifts the eyelid.

The superior tarsal muscle hypersensitive to adrenaline.

It's just pulling too hard, keeping the eyes wide open.

You look startled.

OK, so that's the stare.

Let's talk about the big one, Graves' disease.

This is the most common cause of hyperthyroidism.

And it has a very specific triad of symptoms, one of which is exothelmos, the actual bulging of the eyes.

Right.

Graves' is an autoimmune disease.

Your body produces an antibody called TSI, thyroid stimulating immunoglobulin.

This antibody mimics TSH.

It binds to the thyroid receptor and screams,

go!

So the thyroid just ramps up production.

It does, but, and here is the key insight for the eyes, that TSH receptor isn't only on the thyroid.

Where else is it?

It is also found on the fibroblast, the connective tissue cells located behind the eye.

Oh, wow.

So the antibody attacks the tissue behind the eyeball.

It stimulates those fibroblasts to produce glycosaminoglycans.

OK.

Think of it as a thick, water -holding jelly.

It also causes inflammation, so the confined space behind the eye fills up with the swelling and physically pushes the eyeball forward.

That is terrifying.

It's not just the eyelids pulling back.

The orbit is literally running out of room.

Correct.

And that's why treating the thyroid hormone levels helps the stare, but it often doesn't fix the bulge.

Ah, because the damage is already done.

The structural damage behind the eye is a separate consequence of the antibody.

The third part of the Graves' triad is dermopathy.

Specifically, pretimul mixed edema.

This is a similar mechanism to the eye.

You get that accumulation of glycosaminoglycans in the skin on the shins.

Right.

It becomes thickened, scaly, and doughy.

Before we leave Graves, I want to visualize the gland itself.

If we put a slice of a Graves thyroid under the microscope,

what does a gland that is being whipped into overdrive look like?

It looks frantic.

You see hyperplastic follicles.

And there is a very specific high -yield description the text uses,

scalloped colloid.

Scalloped, like a bite mark.

Exactly.

Imagine the colloid, that pool of stored hormone in the center of the follicle, is being eaten away at the edges by the thyroid cell.

OK.

They are resorbing it so fast to pump it into the blood that they leave these white scalloped spaces at the margin.

That white space is the visual evidence of the gland working overtime.

That's a great visual.

Now let's flip the switch.

We go from high idle to the slowdown.

Hypothyroidism.

This is the exact opposite.

The metabolic rate drops.

The fire goes out.

So instead of heat intolerance, these patients are freezing.

They are cold sensitive.

They are fatigued.

The gut slows down, leading to constipation.

Right.

And physically, you see mixodema.

We use that word mixodema with Graves, but here it seems more generalized.

In hypothyroidism, mixodema refers to the accumulation of proteoglycans and water in the tissues generally.

It causes facial puffiness, particularly periorbital edema swelling around the eyes.

OK.

It can cause the tongue to enlarge macroglossia.

The voice deepens.

And the labs are the mirror image of what we just discussed.

Right.

In primary hypothyroidism, the thyroid is broken.

So T4 is low.

Right.

The pituitary sees this and screams at the thyroid to work, so TSH is high.

Low T4, high TSH.

The classic picture.

The text highlights a few specific causes.

Iatrogenic seems to be the big one in the US.

Iatrogenic means doctor caused.

Usually this is the aftermath of treating hyperthyroidism.

We either surgically removed the thyroid or nuked it with radioactive iodine.

We solved the excess, but now we have a deficiency.

And then there is the congenital form.

The text uses the historical term cretinism.

This is a critical diagnosis to catch early.

In developing parts of the world, this is often due to iodine deficiency in the mother.

Right.

But in the West, it's usually thyroid dysgenesis.

The gland just didn't form correctly in the fetus.

Why is that so catastrophic for an infant compared to an adult?

Because thyroid hormone is essential for neurodevelopment and bone growth.

Oh, wow.

Without it, the infant suffers mental retardation and stunted skeletal growth classic dwarfism.

You might also see a pot belly and an umbilical hernia.

It's a systemic failure of development.

Moving on to inflammation.

The text breaks down thyroiditis into three flavors, but Hashimoto thyroiditis is clearly the headliner.

Hashimoto is the number one non -nitrogenic cause of hypothyroidism in the US.

Like Graves, it's autoimmune.

But instead of stimulating the gland, the immune system decides to destroy it.

It's a scorched earth policy.

It is.

It's primarily a T -cell mediated destruction.

You see intense inflammation.

If we look at the histology for Hashimoto, there's a specific cell type mentioned that seems to show up on every exam, the Hercel cell.

Yes.

Hercel cells are these thyroid epithelial cells that become large and pink eosinophilic in response to the chronic injury.

Okay.

But the other thing you see is lymphoid follicles with germinal centers.

Wait, germinal centers like you'd see in a lymph node?

Exactly.

The inflammation is so chronic and organized that the thyroid actually starts to look like a lymph node.

Wow.

And that leads to the so what for this disease?

The risk of malignancy.

Right.

Patients with Hashimoto thyroiditis have an increased risk of developing non -Hodgkin B -cell lymphoma.

That chronic immune agitation basically pushes the B -cells too far until they turn malignant.

That is a critical correlation, so it's not just about replacing the hormone, it's about monitoring for lymphoma.

Correct.

You have to be vigilant.

Briefly, let's contrast that with subacute thyroiditis or D -quervain thyroiditis.

The text emphasizes one major symptom difference.

Pain.

Pain.

Hashimoto is painless.

Subacute thyroiditis hurts.

The patient will have a tender thyroid and might complain of pain on swallowing.

And the trigger is different too.

It's typically viral.

It follows a flu -like illness.

Histologically, it's a granulomatous inflammation.

The good news is it's usually self -limited.

The thyroid gets damaged, spills some hormone,

transient hyperthyroidism, then recovers.

And the third one is the rare dramatic one, renal thyroiditis.

The rock hard thyroid.

Rock hard.

This is a mysterious fibrosis where the thyroid is replaced by dense scar tissue.

It feels hard as a stone on exam.

The danger here seems to be anatomical.

Yes.

The fibrosis extends beyond the thyroid.

It can grab onto the trachea, causing breathing issues, stridor.

It can grab the esophagus.

Wow.

And clinically, a hard fixed neck mass screams cancer.

You often have to biopsy it just to prove it's not a carcinoma.

Speaking of cancer, let's move to section two.

Thyroid neoplasia.

Lumps and bumps.

This is a huge topic.

The first thing to know is that thyroid nodules are extremely common, but the vast majority are benign.

The text starts with a benign lesion, the follicular adenoma.

It points us to figure 25 to one.

I'm looking at this image and I see a distinct circle of tissue.

That image is the holy grail of thyroid diagnosis.

On the left, you have the tumor, the adenoma.

On the right, normal thyroid.

But look at the line between them.

It's a thick white band.

That is the fibrous capsule.

In a follicular adenoma, that capsule is intact.

The tumor is completely contained.

It's pushing on the neighbors, but it hasn't broken into their house.

Hold that thought, because I know that capsule is gonna be the deal breaker for cancer later.

Let's talk about the malignant tumors.

The text lists four main types.

First up is papillary carcinoma.

This is the most common, accounting for 80 % of thyroid cancers.

The prognosis is excellent.

Good to hear.

But the histology is what makes it famous.

Orphan Annie Eye, nuclei.

It's a bizarre name, isn't it?

It is.

It refers to the clear empty appearance of the nuclei in the cancer cells.

They look like the blank eyes of the cartoon character, Little Orphan Annie.

That's a visual you can't unsee.

You also see nuclear grooves lines running through the nucleus.

And you see somomabodies.

Somomabodies.

These are microscopic concentric calcifications.

If you see somomabodies in the neck, you think papillary carcinoma.

And a major risk factor.

Prior radiation exposure.

We see this in patients who had neck radiation as children.

Next is follicular carcinoma.

Now, we have to go back to that capsule we looked at with the adenoma.

How do we tell the difference between a benign follicular adenoma and a malignant follicular carcinoma?

This is the most important concept in thyroid neoplasia.

You cannot tell them apart just by looking at the cells.

Really?

The cells look identical.

So needle biopsy is useless.

A needle biopsy pulls out cells.

It doesn't show you the architecture.

To diagnose follicular carcinoma, you need to see the edge of the tumor.

You must see capsule or invasion.

So the tumor has to be breaking through that white line.

Exactly.

If it breaks the capsule or invades the blood vessels, it's carcinoma.

If it stays inside, it's an adenoma.

You have to remove the lump to make the diagnosis.

And unlike papillary carcinoma, which spreads via lymph nodes.

Follicular loves the blood, right?

It spreads hematogenously.

It likes to travel to the bones or the lungs.

The third type is medullary carcinoma.

This one feels like the odd cousin.

It's not even from the same cell type.

Correct.

It doesn't arise from the follicular cells that make thyroid hormone.

It arises from the parafollicular C cells.

The C cells, which normally secrete.

Calcitonin.

Calcitonin.

So these tumors produce high levels of calcitonin.

And interestingly, that calcitonin deposits within the tumor as amyloid.

So structurally, you see sheets of malignant cells in an amyloid stroma.

And finally, anaplastic carcinoma.

This is the nightmare scenario.

It's rare, usually in the elderly.

It's undifferentiated, meaning it has lost all resemblance to thyroid tissue.

It grows rapidly, invades the trachea, and is almost always fatal.

It's one of the most aggressive, solid tumors in the human body.

Let's move down, or rather to the back of the thyroid, to the parathyroid glands.

Section three.

These four tiny glands have one job.

Calcium regulation.

Their job is to keep serum calcium up.

If calcium drops, they secrete parathyroid hormone, PTH.

So in primary hyperparathyroidism, we have too much PTH, usually from a benign adenoma.

The text gives us a rhyme for the symptoms.

Stones, bones, groans, and psychiatric overtones.

I wanna unpack the bones part.

The bones part is classic pathology.

High PTH tells the osteoclasts, the bone -eating cells, to go into overdrive.

They dissolve bone to release calcium into the blood.

So the bones become weak osteoporosis.

But specifically, you get a condition called osteoiasphibrosis cystica.

The text mentions brown tumors.

Now, these aren't true cancers.

They are cystic spaces left behind in the bone where the osteoclasts have eaten away the structure.

They fill with hemorrhage and old blood, which gives them a brown color.

So your bones are literally turning into Swiss cheese filled with old blood.

That is the reality of unchecked PTH.

And stones, refers to kidney stones, obviously.

Growns is the constipation from high calcium.

Now, secondary hyperparathyroidism.

This isn't the gland's fault, is it?

No, the parathyroid is just doing its job.

This is usually seen in chronic renal failure.

Walk us through the mechanism.

Okay.

The kidneys fail.

They stop activating vitamin D and they stop excreting phosphate.

Phosphate binds up the calcium, so free calcium levels drop.

The parathyroid sense this low calcium and scream, we need more.

And they grow.

They undergo hyperplasia.

They're working overtime to compensate for the kidneys failure.

On the flip side, hyperparathyroidism.

Too little PTH.

This is usually surgical.

We accidentally remove the parathyroids when taking out the thyroid.

Or it's genetic, like in DeGeorge syndrome.

And the symptoms are all about neuromuscular irritability.

Low calcium makes nerves twitchy.

Twitchy.

You get muscle spasms, tingling lips, and tingling fingers.

It's a very distinct clinical picture.

All right, we are leaving the neck.

Let's go up to the command center.

Section four, pituitary hypothalamus and pineal gland.

The master gland.

But even the master has a boss, the hypothalamus.

Pituitary adenomas are the main pathology here.

But before we even talk about hormones, we have to talk about physics.

The pituitary sits in a tiny bony saddle called the selatursica.

It's high -priced real estate with no room for expansion.

So if a tumor grows a macrodonoma, it has nowhere to go but up.

And what's directly above it?

The optic chiasm.

This is where the optic nerves from your eyes cross over.

So a pituitary tumor physically pushes on the optic nerves.

Specifically, it pushes on the crossing fibers, which carry vision from your peripheral fields.

So the patient develops bitemporal hemianopsia.

They lose their peripheral vision on both sides.

It's like wearing horse blinders.

That is such a specific physical finding.

Now let's talk about the functional tumors.

What are they secreting?

The most common is a prolactinoma.

It pumps out prolactin.

In women, this causes galactoria milk production when not nursing, and amenorrhea, the loss of periods.

In men, it's subtler loss of libido.

Then there is the growth hormone adenoma.

This leads to one of the most visually striking diseases in history.

If it happens in kids before their growth plates close, they get gigantism.

They grow incredibly tall.

But in adults, the plates are closed.

The bones can't get longer, so they get thicker.

Acromegaly.

Yes.

Figure 25 -2 in the text shows this.

The jaw protrudes, prognathism.

The forehead gets heavy.

The hands and feet enlarge.

Patients often say their wedding ring doesn't fit anymore or their shoe size went up at age 40.

And it's not just bones.

The organs grow, too.

The heart grows, cardiomegaly.

The tongue grows.

It's a systemic overgrowth.

Now what if the pituitary fails?

Hypopituitarism.

There is a specific syndrome mentioned related to pregnancy, Sheehan syndrome.

This is a fascinating hemodynamic tragedy.

During pregnancy, the pituitary doubles in size to produce all the hormones needed for the baby.

But its blood supply doesn't double.

It becomes very sensitive to oxygen delivery.

It's living on the edge.

Exactly.

So if the mother has a massive hemorrhage during delivery and her blood pressure crashes, the pituitary is the first organ to stroke out.

It undergoes infarction.

And the result is panhypopituitarism.

The mother survives the birth, but then she can't breastfeed, no prolactin.

Her periods never return.

No LHFSH.

She gets cold and fatigued.

No TSH.

Wow.

It's a silent, sudden failure of the master gland.

Moving to the posterior pituitary, this is the domain of ADH, antidiuretic hormone.

ADH controls water retention.

So if you have too little, you get diabetes insipidus.

Which has nothing to do with sugar.

Nothing, it's about water.

Without ADH, the kidney can't concentrate urine.

You pee out liters and liters of dilute water.

You get incredibly thirsty polydipsia.

And the opposite,

SIADH, syndrome of inappropriate ADH.

Too much ADH.

You hold onto all your water.

This dilutes your blood sodium, leading to hyponutremia.

Which is dangerous.

Very.

If it gets severe, the brain swells cerebral edema.

The text flags a specific cause for SIADH that links us back to cancer.

Small cell lung cancer.

This tumor loves to produce ectopic hormones and ADH is a favorite.

So a patient presenting with low sodium might actually have lung cancer.

All right, let's drop down to the abdomen.

Section five,

the adrenal glands.

We have the cortex on the outside and the medulla on the inside.

Let's start with the cortex and Cushing syndrome.

Cushing syndrome is the result of excess glucocorticoids.

Mainly cortisol.

This is another diagnosis you can almost spot from across the room.

The phenotype is unmistakable.

Truncal obesity fat in the belly, but the arms and legs are thin due to muscle wasting.

Okay.

A buffalo hump of fat on the upper back.

Moon faces.

And the skin is thin and fragile with purple abdominal stray eye.

But diagnosing why a patient has high cortisol seems to be the hardest logic puzzle in endocrine pathology.

It is.

The text provides a flow chart in figure 25 -3.

I wanna act this out.

Cause it's the only way to really get the feedback loops.

Let's play detective.

Okay, I have a patient.

They have the moon face, the buffalo hump.

I measure their cortisol.

It is sky high.

Step one.

I look at the manager.

I measure ACTH.

Okay.

If the adrenal gland is acting alone, say an adrenal adenoma, it's pumping out cortisol.

That high cortisol should tell the pituitary to shut up.

So ACTH should be low.

So if ACTH is low, I know the problem is in the adrenal or the patient is taking steroids.

Case closed.

Case closed.

But what if ACTH is high GH?

If ACTH is high, then the pituitary is driving the bus or something is driving the bus.

The high cortisol isn't turning off the signal.

So now we have two suspects.

Suspect one, a pituitary tumor, Cushing disease.

Suspect two, an ectopic tumor, like that small cell lung cancer again, making its own ACTH.

Both produce high ACTH.

How do we tell them apart?

We use the high dose dexamethasone suppression test.

This is the interrogation.

The interrogation.

Dexamethasone is a potent synthetic steroid.

We flood the system with it.

And we watch to see who blinks.

A pituitary tumor is rogue, but it's still pituitary tissue.

It retains a tiny shred of feedback sensitivity.

If you hit it with a massive dose of steroids, it will lower its ACTH output.

It suppresses.

But the lung cancer.

The lung cancer is an anarchist.

It's not endocrine tissue.

It has no receptors for feedback.

You can give all the dexamethasone you want.

The lung tumor keeps pumping out ACTH.

It does not suppress.

It does not suppress.

So suppression equals pituitary.

No suppression equals ectopic lung.

That is brilliant.

And that distinction tells the surgeon whether to operate on the brain or the chest.

Let's briefly touch on the other cortical hormones.

Hyperaldosteronism.

Aldosterone's job is to save sodium and dump potassium.

Okay.

So if you have too much, usually from an adenoma called Kahn syndrome, you get hypertension from the salt and hypokalemia, low potassium.

And adrenal insufficiency.

When the adrenals fail, the acute form is a horror story called Waterhouse -Fredrickson syndrome.

This is high drama.

It's typically seen in children with severe sepsis, often meningocosemia.

The bacteria leads to disseminated intravascular coagulation, DIC.

So clots forming everywhere.

Clots and bleeding.

Specifically, massive bilateral hemorrhage into the adrenal glands.

The glands essentially turn into sacs of blood.

Oh my.

They infarct.

The body loses all cortisol and adrenaline instantly.

The patient goes into shock and it's often fatal.

And the chronic form is Addison's disease.

This is slower destruction, usually autoimmune or TB.

But there is a fascinating symptom here.

Hyperpigmentation.

The patient looks deeply tanned.

Why does adrenal failure make you tan?

It's the feedback loop again.

The pituitary sees low cortisol and screams, work harder by pumping out massive amounts of ACTH.

Right.

Now ACTH is made from a larger precursor protein called POMC.

POMC also contains melanocytes stimulating hormone, MSH.

So as a by -product of making all that ACTH, you make MSH.

And you get the tan.

It's a telltale sign of primary adrenal failure.

Now let's go to the center of the gland.

The medulla, pheochromocytoma.

This is a tumor of the chromophin cells.

These cells make catecholamines, epinephrine and norepinephrine.

So basically a tumor made of pure adrenaline.

Exactly.

And the symptoms are exactly what you'd expect from an adrenaline overdose, but they are episodic.

Episodic.

The patient is fine, then suddenly, bam.

Severe headache, heart palpitations, sweating, and massive hypertension.

It comes in spells.

Yes.

And there is a rule of 10s for this tumor that makes it easy to remember.

Walk us through it.

10 % are malignant, 10 % are bilateral, both adrenals.

10 % are extra adrenal, found outside the gland.

10 % are familial, and 10 % occur in children.

Speaking of familial, that leads us to section six.

Multiple endocrine neoplasia and mannivalums.

This is where we connect the dots.

These are genetic syndromes where patients get tumors in multiple glands.

If you see a patient with a pituitary tumor and a parathyroid tumor, you have to think men.

There are three main types, Men 1 or Werner syndrome.

The mnemonic is the three Ps.

One, pituitary adenomas.

Two, parathyroid hyperplasia.

Three, pancreatic tumors, like gastronomas.

Three Ps.

The gene is MEN1.

Then Men 2A.

Here we see medullary carcinoma of the thyroid.

That's a calcitonin tumor.

We see pheochromocytoma, the adrenaline tumor, and parathyroid hyperplasia.

The gene is RET.

And Men 2B.

Also medullary thyroid carcinoma and pheochromocytoma.

But instead of the parathyroid, these patients have mucosal neuromas.

What are those?

Bumps on the lips and tongue.

And they have a marfanoid, habitus, tall, long limbs, also caused by RET mutations.

So medullary thyroid carcinoma plus pheo is the core of MN2.

Parathyroid makes it 2A.

Neuromas make it 2B.

You got it.

We have arrived at the final massive section.

Section seven, diabetes mellitus,

the systemic metabolic beast.

We can't do endocrine without diabetes.

It is the ultimate metabolic disruption.

The diagnosis is straightforward high sugar.

But the distinction between type one and type two is foundational.

Type one is an autoimmune disease.

T lymphocytes attack the beta cells in the pancreas.

It's a type IV hypersensitivity.

So the factory is destroyed.

Completely.

Absolute insulin deficiency.

These patients, usually kids, need insulin to survive.

If they don't get it, they go into ketoacidosis, DKA.

The body starts burning fat for fuel because it can't use sugar, producing ketones.

Stress that with type two.

Type two is about resistance.

The pancreas is making insulin, sometimes tons of it, but the bi -cells stop listening.

It's associated with obesity.

And historically we see insulitis in type one.

But what do we see in type two?

Amyloid deposition in the islets.

The overworked beta cells burn out and get replaced by amyloid.

Now, the pathology of complications.

Diabetes isn't just about high sugar.

It's about what that sugar does to blood vessels.

It accelerates atherosclerosis.

That's why the number one cause of death in diabetics is myocardial infarction.

It also causes peripheral vascular disease gangrene of the toes.

But it also hits the small vessels.

The eyes.

Diabetic retinopathy.

The text describes two phases.

Non -proliferative, where the vessels get weak and leaky, you see hemorrhages and microanarysms.

And proliferative.

Proliferative implies growth.

The retina is starving for oxygen.

So it tries to grow new blood vessels,

neovascularization.

But these new vessels are weak and fragile.

They burst and bleed, leading to blindness.

Figure 25 to four shows the fundoscopic view.

It's a mess.

You see venous beading.

The veins look like a string of beads.

You see hemorrhages.

It's a retina under siege.

And the kidneys.

Nephropathy.

The filters, the glomeruli get scarred.

You see nodular glomerulosclerosis.

It's a leading cause of renal failure, requiring dialysis.

And the nerves.

Peripheral neuropathy.

The sugar damages the nerves, usually in a stocking glove distribution.

Stocking glove.

Patients lose sensation in their feet.

They step on attack, don't feel it, it gets infected.

And because blood flow is poor, it doesn't heal.

It's a vicious cycle.

Wow.

We have traversed the entire body.

From the colloid in the neck to the eyelets in the pancreas.

It's a journey.

So what does this all mean when you zoom out?

If we synthesize this, endocrine pathology is really about the fragility of balance.

Whether it's the feedback loop between the pituitary and the thyroid, or the delicate balance of blood sugar by the pancreas, or the calcium set point in the parathyroids.

It's amazing how these distinct glands, which are anatomically miles apart, are clinically connected.

You see in the MN syndromes, where a gene mutation links the thyroid to the adrenal.

Absolutely.

You see in diabetes, where the pancreas destroys the kidney in the eye.

Absolutely.

No organ is an island in the endocrine system.

When one node fails due to autoimmunity like Graves or Hashimoto or a tumor like an adenoma, the ripple effects are felt in every cell of the body.

Here's a final thought for you to mull over.

We talk about how the thyroid drives metabolism and the adrenals drive the stress response.

Think about how many of the symptoms we discussed.

Anxiety, palpitations, weight changes, fatigue are things people experience daily in a tribute to stress or lifestyle.

It makes you realize how powerful these invisible chemical messengers really are in defining our reality.

The chemistry dictates the experience.

That is a profound thought.

We are in many ways at the mercy of our hormones.

Thanks for diving deep with us today.

Always a pleasure.

This has been the Last Minute Lecture Team signing off.

Catch you on the next deep dive.

ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.

Chapter SummaryWhat this audio overview covers
Endocrine pathology encompasses dysfunction across multiple hormone-producing glands, each presenting distinct etiological mechanisms and clinical consequences that require systematic understanding for diagnostic and therapeutic purposes. Thyroid disorders span autoimmune conditions like Graves disease, characterized by thyroid-stimulating immunoglobulin binding to TSH receptors, and Hashimoto thyroiditis, involving progressive lymphocytic infiltration and follicular destruction, alongside structural abnormalities ranging from benign multinodular enlargement to malignant neoplasms including papillary, follicular, medullary, and anaplastic carcinomas with varying metastatic potentials and prognoses. Parathyroid dysfunction disrupts calcium homeostasis through either excessive hormone secretion in primary hyperparathyroidism from adenomatous growth or secondary elevation from chronic renal disease, contrasting sharply with hypoparathyroidism observed in developmental syndromes like DiGeorge syndrome where inadequate parathyroid tissue results in hypocalcemia and neuromuscular complications. Pituitary pathology manifests through anterior lobe adenomas that produce excessive prolactin or growth hormone, with the latter causing acromegaly through insulin-like growth factor elevation, while posterior lobe dysfunction impairs osmoregulation through deficient antidiuretic hormone in central diabetes insipidus or excessive secretion in the syndrome of inappropriate antidiuretic hormone. Adrenal cortical disorders including Cushing syndrome from excessive glucocorticoid production, Conn syndrome from primary aldosterone overproduction, and congenital adrenal hyperplasia from enzymatic defects in steroid synthesis represent distinct pathophysiological mechanisms, while medullary tumors like pheochromocytomas produce catecholamine excess and acute or chronic adrenal insufficiency—including Waterhouse-Friderichsen syndrome and Addison disease—result from glandular destruction or dysfunction. Multiple Endocrine Neoplasia syndromes represent inherited cancer predisposition disorders with specific genetic mutations determining whether multiple tumors develop in parathyroid, pancreatic islet, anterior pituitary, or medullary thyroid tissues. Diabetes Mellitus pathology fundamentally diverges between Type 1 involving immune-mediated beta-cell destruction versus Type 2 characterized by progressive insulin resistance and beta-cell dysfunction, with both conditions generating chronic microvascular complications affecting the retina, kidney, and peripheral nerves through hyperglycemia-induced structural and functional damage.

Using this chapter to study? Last Minute Lecture is free and student-run. If it helped, consider supporting the project.

Support LML ♥